We use cookies to improve your experience and to help us understand how our site is used. You can find out more about your options on our
Cookies page.
About Cookies
Most websites these days use cookies to store and retrieve information. Some of this information might be about you,
your preferences or your device and is mostly used to help the website work in the way you expect.
This information doesn’t usually directly identify you but can give you a more personalized experience.
We will never sell any of your personally identifiable information, whether gathered using a cookie or otherwise.
We respect your right to privacy, so you can choose whether or not some cookies are enabled on our website.
However, disabling some cookies can impact your experience and the services we are able to offer. For more information see our Cookie settings and Privacy Policy.
Essential Cookies (Required)
These cookies are essential for the website to work properly and can’t be turned off.
They don’t collect personal information.
We also use them to understand how the site is used.
You can choose to block these cookies in your browser, but parts of the site might not work as expected.
Analytics Cookies (Optional)
These cookies help us improve our website and keep content relevant.
We use third-party tools to analyse information gathered by cookies and understand how visitors use our website.
We only use information gathered by cookies internally. See our Privacy Policy.
You can turn these cookies off by clicking "Reject optional cookies", but parts of the site might not work as expected.
Below is a text only representation of the Patient Information Leaflet (ePIL).
The text only version may be available in large print, Braille or audio CD.
For further information call emc accessibility on
0800 198 5000.
The product code(s) for this leaflet is: PL 17780/1210.
▼This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See the end of section 4 for how to report side effects.
Read all of this leaflet carefully before you are given this medicine because it contains important information for you.
Keep this leaflet. You may need to read it again.
If you have any further questions, ask your doctor or pharmacist
This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
If you get any serious side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.
What is in this leaflet
1. What Tolvaptan is and what it is used for 2. What you need to know before you take Tolvaptan 3. How to take Tolvaptan 4. Possible side effects 5. How to store Tolvaptan 6. Contents of the pack and other information
1. WHAT TOLVAPTAN IS AND WHAT IT IS USED FOR
This medicine contains the active substance tolvaptan which blocks the effect of vasopressin, a hormone involved in the formation of cysts in the kidneys of ADPKD patients. By blocking the effect of vasopressin, Tolvaptan slows the development of kidney cysts in patients with ADPKD, reduces symptoms of the disease and increases urine production.
Tolvaptan is a medicine used to treat a disease called “autosomal dominant polycystic kidney disease” (ADPKD). This disease causes growth of fluid-filled cysts in the kidneys, which put pressure on surrounding tissues and reduce kidney function, possibly leading to kidney failure. Tolvaptan is used to treat ADPKD in adults with chronic kidney disease (CKD) stages 1 to 4 with evidence of rapidly progressing disease.
2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE TOLVAPTAN
Do not take Tolvaptan if:
you are allergic to tolvaptan or any of the other ingredients of this medicine (listed in section 6) or if you are allergic to benzazepine or benzazepine derivatives (e.g. benazepril, conivaptan, fenoldopam mesylate or mirtazapine)
you have been told that you have raised levels of liver enzymes in your blood which do not allow treatment with tolvaptan
your kidneys do not work (no urine production)
you have a condition which is associated with a very low blood volume (e.g. severe dehydration or bleeding)
you have a condition which increases the sodium in your blood
you do not realise when you are thirsty
you are pregnant
you are breastfeeding.
Warnings and precautions
Talk to your doctor before taking Tolvaptan if you:
suffer from liver disease.
cannot drink enough water (see “drinking enough water” below) or have to restrict your fluid intake.
have difficulties urinating (e.g. have an enlarged prostate).
suffer from too high or too low blood sodium.
had an allergic reaction in the past to benzazepine, tolvaptan or other benzazepine derivatives (e.g. benazepril, conivaptan, fenoldopam mesylate or mirtazapine), or to any of the other ingredients of this medicine (listed in section 6).
have diabetes.
have been told you have high levels of a chemical called uric acid in your blood (which may have caused attacks of gout).
have advanced kidney disease.
This medicine may cause your liver to not work properly. Therefore, please inform your doctor immediately if you have signs that could indicate potential liver problems such as:
nausea
vomiting
fever
tiredness
loss of appetite
pain in the abdomen
dark urine
jaundice (yellowing of skin or eyes)
itching of your skin
flu-like syndrome (joint and muscle pain with fever)
During treatment with this medicine, your doctor will arrange monthly blood tests to check for changes in your liver function.
Drinking enough water
This medicine causes water loss because it increases your urine production. This water loss may result in side effects such as dry mouth and thirst or even more severe side effects like kidney problems (see section 4). It is therefore important that you have access to water and that you are able to drink sufficient amounts when you feel thirsty. Before bed-time you must drink 1 or 2 glasses of water even if you do not feel thirsty and you must also drink water after you urinate at night. Special care must be taken if you have a disease that reduces appropriate fluid intake or if you are at an increased risk of water loss e.g. in case of vomiting or diarrhoea. Due to the increased urine production, it is also important that you always have access to a toilet.
Children and adolescents
Do not give this medicine to children and adolescents (under age of 18 years) because it has not been studied in these age groups.
Other medicines and Tolvaptan
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including medicines obtained without a prescription.
The following medicines may increase the effect of Tolvaptan:
amprenavir, atazanavir, darunavir/ritonavir and fosamprenavir (used to treat HIV/AIDS),
aprepitant (used to avoid nausea and vomiting in chemotherapy),
crizotinib and imatinib (used to treat cancer),
ketoconazole, fluconazole or itraconazole (used to treat fungal infections),
macrolide antibiotics like erythromycin or clarithromycin,
verapamil (used to treat heart diseases and high blood pressure),
diltiazem (used to treat high blood pressure and chest pain).
The following medicines may lower the effect of Tolvaptan:
phenytoin or carbamazepine (used to treat epilepsy),
rifampicin, rifabutin or rifapentine (used to treat tuberculosis),
St. John’s Wort (a traditional herbal medicinal product for the relief of slightly low mood and mild anxiety).
Tolvaptan may increase the effect of the following medicines:
digoxin (used to treat irregular heart beat and heart failure),
dabigatran (used to thin the blood),
methotrexate (used to treat cancer, arthritis),
ciprofloxacin (an antibiotic),
sulfasalazine (used to treat inflammatory bowel disease or rheumatoid arthritis),
metformin (used to treat diabetes).
Tolvaptan may lower the effect of the following medicines:
vasopressin analogues such as desmopressin (used to increase blood clotting factors or to control urine output or bedwetting).
These medicines can affect or be affected by Tolvaptan:
diuretics (used to influence the production of urine). Taken with tolvaptan these may increase the risk of side effects due to water loss or may cause kidney problems.
diuretics or other medicines for the treatment of high blood pressure. Taken with tolvaptan these may increase the risk of low blood pressure when you stand up from sitting or lying down.
medicines which increase the level of sodium in your blood or which contain large amounts of salt (e.g. tablets that dissolve in water and indigestion remedies). These may increase the effect of tolvaptan. There is a risk that this may lead to too much sodium in your blood.
It may still be alright for you to take these medicines and tolvaptan together. Your doctor will be able to decide what is suitable for you.
Tolvaptan with food and drink
Do not drink grapefruit juice when taking this medicine.
Pregnancy, breast-feeding and fertility
Do not take this medicine if you are pregnant or breast-feeding.
Women of childbearing age must use reliable contraceptive measures during use of this medicine.
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Driving and using machines
Some people may feel dizzy, weak or tired after being given Tolvaptan. If this happens to you, do not drive or use any tools or machines.
Tolvaptan contains lactose monohydrate and sodium
If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.
This medicine contains less than 1 mmol sodium (23 mg) per tablet, that is to say essentially ‘sodium-free’.
3. HOW TO TAKE TOLVAPTAN
Tolvaptan can only be prescribed by doctors who are specialised in the treatment of ADPKD. Always take this medicine exactly as your doctor has told you.
Check with your doctor or pharmacist if you are not sure.
Dose
The daily amount of tolvaptan is split into two doses, one bigger than the other. The higher dose should be taken in the morning when you wake up, at least 30 minutes before the morning meal. The lower dose is taken 8 hours later.
The dose combinations are:
45 mg + 15 mg
60 mg + 30 mg
90 mg + 30 mg
Your treatment will normally start with a dose of 45 mg in the morning and 15 mg 8 hours later. Your doctor may gradually increase your dose up to a maximum combination of 90 mg on waking and 30 mg after 8 hours. To find the best dose your doctor will regularly check how well you are tolerating a prescribed dose. You should always take the highest tolerable dose combination prescribed by your doctor.
If you take other medicines, which can increase the effects of tolvaptan you may receive lower doses. In this case your doctor may prescribe you tolvaptan tablets with 30 mg or 15 mg tolvaptan which have to be taken once a day in the morning.
Method of administration
Swallow the tablets without chewing, with a glass of water. The morning dose is to be taken at least 30 minutes before the morning meal.
The second daily dose can be taken with or without food.
If you take more Tolvaptan than you should
If you have taken more tablets than your prescribed dose, drink plenty of water and contact your doctor or your local hospital immediately.
Remember to take the medicine pack with you so that it is clear what you have taken. If you take the higher dose very late in the day you may have to go to the toilet at night more frequently.
If you forget to take Tolvaptan
If you forget to take your medicine, you should take the dose as soon as you remember on the same day. If you do not take your tablets on one day, take your normal dose on the next day. DO NOT take a double dose to make up for forgotten individual doses.
If you stop taking Tolvaptan
If you stop taking this medicine your kidney cysts may grow as fast as they did before you started treatment with tolvaptan. Therefore, you should only stop taking this medicine if you notice side effects requiring urgent medical attention (see section 4) or if your doctor tells you to.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
4. POSSIBLE SIDE EFFECTS
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Serious side effects:
If you notice any of the following side effects, you may need urgent medical attention. Stop taking tolvaptan and immediately contact a doctor or go to the nearest hospital if you:
find it difficult to urinate.
experience swelling of the face, lips or tongue, itching, generalised rash, or severe wheezing or breathlessness (symptoms of an allergic reaction).
Tolvaptan may cause your liver not to work properly.
Consult your doctor if symptoms of nausea, vomiting, fever, tiredness, loss of appetite, pain in the abdomen, dark urine, jaundice (yellowing of skin or eyes), itching of your skin or joint and muscle pain with fever occur.
Other side effects:
Very common (may affect more than 1 in 10 people)
thirst (requiring excessive drinking of water)
headache
dizziness
diarrhoea
dry mouth
increased need to urinate, to urinate at night, or to urinate more frequently
fatigue
Common (may affect up to 1 in 10 people)
dehydration
high levels of sodium, uric acid and blood sugar
decreased appetite
taste changes
gout
difficulty sleeping
fainting
heart pounding
shortness of breath
belly pain
full or bloated or uncomfortable feeling in the stomach
constipation
heartburn
liver function abnormal
dry skin
rash
itching
hives
joint pain
muscle spasms
muscle pain
general weakness
raised levels of liver enzymes in the blood
weight loss
weight gain
Uncommon (may affect up to 1 in 100 people)
increase of bilirubin (a substance that can cause yellowing of skin or eyes) in the blood
Not known (frequency cannot be estimated from the available data)
allergic reactions (see above)
generalised rash
acute liver failure (ALF)
increased level of creatine phosphokinase (an enzyme that measures the muscle and heart function) in the blood
Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
By reporting side effects, you can help provide more information on the safety of this medicine.
5. HOW TO STORE TOLVAPTAN
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton or wallet after EXP. The expiry date refers to the last day of that month.
This medicinal product does not require any special storage conditions.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
6. CONTENTS OF THE PACK AND OTHER INFORMATION
What Tolvaptan contains
The active substance is Tolvaptan. Each Tolvaptan 15 mg tablet contains 15 mg tolvaptan. Each Tolvaptan 30 mg tablet contains 30 mg tolvaptan. Each Tolvaptan 45 mg tablet contains 45 mg tolvaptan. Each Tolvaptan 60 mg tablet contains 60 mg tolvaptan. Each Tolvaptan 90 mg tablet contains 90 mg tolvaptan.
The other ingredients are lactose monohydrate, cellulose microcrystalline, croscarmellose sodium, povidone, magnesium stearate.
What Tolvaptan looks like and contents of the pack
The different strengths of Tolvaptan tablets have different shapes and embossing:
Tolvaptan 15 mg tablets: White to off white, triangular, 6.1 x 5.7 mm tablets with marking “C6” debossed on one side.
Tolvaptan 30 mg tablets: White to off white, round 7.5 mm tablets with marking “C7” debossed on one side.
Tolvaptan 45 mg tablets: White to off white, square 8.5 x 8.5 mm tablets with marking “C8” debossed on one side.
Tolvaptan 60 mg tablets: White to off white, barrel, 11.3 x 7.0 mm tablets with marking “C9” debossed on one side.
Tolvaptan 90 mg tablets: White to off white, pentagonal, 11.3 x 11.5 mm tablets with marking “C10” debossed on one side.